Checkpoint Therapeutics, Inc. ( CKPT) - Key Metrics
Stock symbol CKPT is outdated, potentially delisted? Maybe it is available on other exchange?
CKPT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$0.23 | -$0.26 | -$0.26 |
| 2024Q2 | $0 | -$0.18 | -$0.17 | -$0.17 |
| 2024Q1 | ? | -$0.33 | -$0.20 | -$0.20 |
| 2023Q4 | $0 | -$0.70 | -$0.25 | -$0.25 |
| 2023Q3 | $0 | -$0.29 | -$0.74 | -$0.74 |
CKPT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -2.48 |
| 2024Q2 | ? | -2.81 |
| 2024Q1 | ? | -1.52 |
| 2023Q4 | ? | -0.82 |
| 2023Q3 | ? | -1.48 |
CKPT
Price: $4.26
52 week price:
Earnings Per Share: -1.28 USD
P/E Ratio: -3.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 87100
Ebitda: -5.9 millionMarket Capitalization: 367.7 million